Eli Lilly and Company

Patent Owner

Follow Compare Create Portfolio

Stats

Details

Technologies

Intl Class Technology # of Patents/ App Rank in Class
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 525 18
 
 
C07D HETEROCYCLIC COMPOUNDS 317 18
 
 
C07K PEPTIDES 94 36
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 58 32
 
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 51 43
 
 
A61M DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY 46 80
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 44 103
 
 
C07C ACYCLIC OR CARBOCYCLIC COMPOUNDS 42 83
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 33 67
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 28 70
  • No Technologies to Display

Top Patents (by citation)

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2014/0180,218 REFILL MODULE FOR AN INJECTION DEVICE Aug 21, 12 Jun 26, 14 [A61M]
2014/0180,244 LOCKING ASSEMBLY FOR PREVENTING DISPENSING OF DOSE FROM MEDICATION DISPENSING DEVICE Dec 17, 13 Jun 26, 14 [A61M]
2014/0170,161 BMP-6 Antibodies Dec 05, 13 Jun 19, 14 [C07K]
2014/0171,411 (THIENO[2,3-b][1,5]BENZOXAZEPIN-4-YL)PIPERAZIN-1-YL COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS Aug 22, 12 Jun 19, 14 [C07D, A61K]
2014/0171,497 ANIMAL SUPPLEMENTS AND COMPOSITIONS CONTAINING SOLUABLE MONENSIN AND METHODS THEREFOR Jul 26, 12 Jun 19, 14 [A23K, A61K]
2014/0162,967 NOVEL PYRAZOLE COMPOUNDS Feb 18, 14 Jun 12, 14 [C07H]
2014/0163,097 ANIMAL SUPPLEMENTS AND FOOD COMPOSITIONS CONTAINING SOLUBLE MONENSIN COMPOSITION, AND METHODS AND PROCESSES THEREFOR Jul 26, 12 Jun 12, 14 [A23K, A61K]
2014/0148,441 6-((S)-1--ETHYL)-3H-1,3-BENZOTHIAZOL-2-ONE AS A TARP-GAMMA 8 DEPENDENT AMPA RECEPTOR ANTAGONIST Nov 20, 13 May 29, 14 [C07D, A61K]
2014/0142,544 MEDICATION INJECTOR APPARATUS WITH DRIVE ASSEMBLY THAT FACILITATES RESET Jan 24, 14 May 22, 14 [A61M]
2014/0135,280 ECTOPARASITICIDAL METHODS AND FORMULATIONS Nov 07, 13 May 15, 14 [A01N]

View all publication…

  • No Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
8,778,648 Enzymes for reduced immunological stress Mar 25, 11 Jul 15, 14 [C12N, A61K]
8,778,887 Therapeutic uses of soluble alpha-Klotho Dec 15, 10 Jul 15, 14 [A61K]
8,778,946 3-substituted-6-(pyridinylmethoxy)-pyrrolopyridine compounds Nov 17, 11 Jul 15, 14 [C07D, A61K]
8,778,984 Aldosterone synthase inhibitor Jun 07, 12 Jul 15, 14 [C07D]
8,772,282 Tetrahydropyrrolothiazine compounds Dec 04, 13 Jul 08, 14 [A61K]
8,772,496 Intermediate and process useful in the preparation of {2-[1-(3,5-bis-trifluoromethyl-benzyl)-5-pyridin-4-yl-1H-[1,2,3]triazol-4-yl]-pyridin-3-yl}-(2-chlorophenyl)-methanone Dec 04, 07 Jul 08, 14 [C07D]
8,765,129 Anti-hepcidin antibodies and uses thereof Dec 07, 12 Jul 01, 14 [A61K]
8,765,960 6-((S)-1- {1-[5-(2-hydroxy-ethoxy)-pyridin-2-yl]-1H-pyrazol-3-YL}-ethyl)-3H-1,3-benzothiazol-2-one as a tarp-gamma 8 dependent AMPA receptor antagonist Nov 20, 13 Jul 01, 14 [C07D, A61K]
8,759,360 Purine compounds Mar 28, 11 Jun 24, 14 [C07D, A61K]
8,748,459 agonists Feb 01, 12 Jun 10, 14 [C07D, A61K]

View all Patent…

  • No Patents to Display

Expired/Abandoned/Withdrawn Patents

Patent # Title Filing Date Issue/Pub Date Intl Class
2013/0023,471 METHODS TO RESTORE GLYCEMIC CONTROL Sep 14, 12 Jan 24, 13 [A61P, A61K]
2012/0323,001 BACE INHIBITORS Aug 16, 12 Dec 20, 12 [C07D]
2012/0302,547 NOVEL MCH RECEPTOR ANTAGONISTS Aug 08, 12 Nov 29, 12 [C07D, A61P, A61K]
2012/0294,855 GLP-1 RECEPTOR AGONIST COMPOUNDS FOR OBSTRUCTIVE SLEEP APNEA Oct 28, 10 Nov 22, 12 [A61P, A61K]
2012/0172,422 Methods of Treatment Using a Prodrug of an Excitatory Amino Acid Mar 13, 12 Jul 05, 12 [A61P, A61K]
2012/0022,140 Method of treating a cancer with a survivin antisense oligonucleotide and paclitaxel Sep 28, 11 Jan 26, 12 [A61P, A61K]
2011/0294,792 PURINE DERIVATIVES AS KINASE INHIBITORS Aug 09, 11 Dec 01, 11 [C07D, A61P, A61K]
2011/0288,032 ENZASTAURIN FOR THE TREATMENT OF CANCER Dec 07, 09 Nov 24, 11 [A61P, A61K]
2011/0212,092 GLUCAGON RECEPTOR ANTAGONISTS May 16, 11 Sep 01, 11 [A61P, A61K, C07K]
2011/0212,977 P70 S6 KINASE INHIBITOR AND MTOR INHIBITOR COMBINATION THERAPY Nov 04, 09 Sep 01, 11 [A61P, A61K]
2011/0207,670 COMPOSITIONS AND METHODS OF USE FOR SOLUBLE THROMBOMODULIN VARIANTS Oct 21, 09 Aug 25, 11 [A61P, A61K, C07K]
2011/0177,195 ENZYMES FOR REDUCED IMMUNOLOGICAL STRESS Mar 25, 11 Jul 21, 11 [A23K]
2011/0105,392 Pegylated Insulin Lispro Compounds Jun 09, 09 May 05, 11 [A61P, A61K, C07K]
2011/0034,373 USE OF AN FGF-21 COMPOUND AND A GLP-1 COMPOUND FOR THE TREATMENT OF OBESITY Jul 30, 08 Feb 10, 11 [A61P, A61K]
2011/0034,511 SUBSTITUTED 2-CARBONYLAMINO-6-PIPERIDINAMINOPYRIDINES AND SUBSTITUTED 1-CARBONYLAMINO-3-PIPERIDINAMINOBENZENES AS 5-HT1F AGONISTS Sep 28, 10 Feb 10, 11 [C07D, A61P, A61K]
2010/0324,140 GLUCAGON RECEPTOR ANTAGONISTS, PREPARATION AND THERAPEUTIC USES Aug 26, 10 Dec 23, 10 [A61P, C07C, A61K]
2010/0286,139 AMINO PYRAZOLE COMPOUND Dec 08, 09 Nov 11, 10 [C07D, A61P, A61K]
2010/0210,583 NOVEL ANTIFOLATE COMBINATION THERAPIES Apr 28, 10 Aug 19, 10 [A61P, A61K]
2010/0196,405 GLP-1 Fc FUSION PROTEIN FORMULATION Jul 09, 08 Aug 05, 10 [A61P, A61K]
2010/0184,764 CYCLOALKYL LACTAM DERIVATIVES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 Mar 19, 10 Jul 22, 10 [C07D, A61K]

View all Patent…

  • No Patents to Display

Top Inventors for This Owner

We are sorry but your current selection exceeds the maximum number of follows () for this membership level. Upgrade to our Level for up to follows!

Owner Follow
Eli Lilly and Company
CANCEL
UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to comparisons!

UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of portfolios () for this membership level. Upgrade to our Level for up to portfolios!

UPGRADE MEMBERSHIP CANCEL

We are sorry but your current selection exceeds the maximum number of patents allowed in portfolios () for this membership level. Upgrade to our Level for up to patents!

UPGRADE MEMBERSHIP CANCEL